Kathleen Moore, RN

In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.

REVERSE-AD trial’s initial results have demonstrated idarucizumab may function as a reversal agent for dabigatran-treated patients with intracranial hemorrhage.

Ethnic/Racial Variations of Intracerebal Variations of Intracerebral Hemorrhage study results indicate hypertension treatment reduces risk of hypertension-related intracerebral hemorrhage.

Postmenopausal women whose last pregnancy occurred at 40 years of age or older may have a greater risk of hemorrhagic stroke.

Substrate-based ablation found superior to ablation targeting only clinical and mappable ventricular tachycardias in patients with ischemic cardiomyopathy.

Cardiorespiratory fitness in early adulthood now linked to lower risk of cardiovascular disease and mortality.

Mechanical thrombectomy after usual care produced better outcomes than usual care alone for acute ischemic stroke caused by large artery occlusion.

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.